Dr. Michael Nabil Megally, MD

Dr. Megally practices at Mount Sinai South Nassau in Oceanside, New York, part of Mount Sinai Health System.

Dr. Megally's NPI, 1942549381, was assigned on February 5, 2013. Dr. Megally holds New York license 285415.

Dr. Megally's primary practice is Mount Sinai South Nassau, at One Healthy Way, Oceanside, NY 11572 in Nassau County. The practice phone is (516) 632-3000. Dr. Megally also practices at South Nassau Communities Hospital, 1 Healthy Way, Oceanside, NY 11572.

Dr. Megally's primary practice is Mount Sinai South Nassau in Oceanside, New York, part of Mount Sinai Health System. Dr. Megally is also affiliated with Mercy Hospital. The medical group on file is Mount Sinai Institute for Liver Medicine. Dmand AI also links Dr. Megally to 2 more group practices and clinics, 1 physician office, 1 home health agency and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Megally practices, 6 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Megally's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Megally is licensed in New York.

CMS data shows 4,126 Medicare services from Dr. Megally across 21 procedure codes in 2024, for 1,086 Medicare patients. Medicare paid $399,543 for them.

CMS counts 1,086 Medicare patients who saw Dr. Megally in 2024. The largest group is 75 to 84, with 377 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 31% are also on Medicaid. Their average risk score is 2.67, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Megally's median patient age at 69, with 44% women.

In 2024, Dr. Megally wrote 1,209 Medicare Part D claims for 252 patients. 36% of them were for generic drugs. CMS names the drug for 984 of them, across 20 drugs with 11 or more claims each, at $1,264,898 in total drug cost. In 2023, CMS named 780 claims across 20 drugs.

Dr. Megally accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Megally as offering telehealth.

Dmand AI links 2 papers to Dr. Megally in 2019. The most frequent topics are Pulmonary Disease, Chronic Obstructive. Dr. Megally's most frequent co-authors are Praveen Reddy Bondalapati, MD, Liam Gross, DO and Viren Kaul, MBBS.

CMS Open Payments shows 588 general payments to Dr. Megally from 39 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 68% of the total. GlaxoSmithKline, LLC. paid the most, $34,715.